We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Phone
Email address available at https://www.ox.ac.uk/gsearch

Websites

Sherlock Group | Immunobiology of Systemic Rheumatic Disease
Principal Investigator, Kennedy Institute

Jonathan Sherlock

Honorary Senior Clinical Research Fellow

Recent publications

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells

Sherlock JP. et al, (2017), Nature Medicine, 18, 1069 - 76

What can rheumatologists learn from translational cancer therapy?

Sherlock JP. et al, (2017), Arthritis Research & Therapy, 15

The critical role of interleukin-23 in spondyloarthropathy

Sherlock J. et al, (2017), Molecular immunology, 57, 38 - 43

Spondyloarthropathy: interleukin 23 and disease modification

Sherlock J. et al, (2017), The Lancet, 385, 2017 - 2018

The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases.

Sherlock J. et al, (2017), Current Opinion in Rheumatology, 27, 71 - 75